ZIMV News and Press, ZimVie Inc.

2024-05-17 15:19:41 ET Summary Zimmer Biomet Holdings, Inc.'s growth has been modest, as investors are concerned about the rise of GLP-1 drugs, raising concerns about future growth. The company's revenue stagnated after spinning off its dental and spine operations, but recently ha...

PALM BEACH GARDENS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that the company will be participating in two upcoming investor conferences. ZimVie will be presenting at the upcoming Stifel 2024 Jaws ...

2024-05-16 09:15:03 ET Needham analyst issues BUY recommendation for ZIMV on May 16, 2024 07:19AM ET. ZIMV was trading at $16.68 at issue of the analyst recommendation. The overall analyst consensus : SELL. Current analyst recommendations are : 1 - Sell recommendations ....

2024-05-11 06:07:06 ET ZimVie Inc. (ZIMV) Q1 2024 Earnings Conference Call May 8, 2024 04:30 PM ET Company Participants Marissa Bych - IR, Gilmartin Group LLC Vafa Jamali - President and CEO Richard Heppenstall - CFO Conference Call Participants Matt ...

2024-05-08 17:45:10 ET Image source: The Motley Fool. ZimVie (NASDAQ: ZIMV) Q1 2024 Earnings Call May 08, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: ZimVie (ZIMV) Q1 2024 Earnings Call Transcript

2024-05-08 17:38:27 ET Gainers: CytomX Therapeutics  ( CTMX ) +77% . Tarsus Pharmaceuticals ( TARS ) +15% . ZimVie  ( ZIMV ) +13% . Equinix ( EQIX ) +11% . Consensus Cloud Solutions ( CCSI ) +10% . Losers: Cardl...

2024-05-08 17:12:26 ET More on ZimVie ZimVie Inc. (ZIMV) Q4 2023 Earnings Call Transcript ZimVie: Shrinking Its Way To Profitability Seeking Alpha’s Quant Rating on ZimVie Historical earnings data for ZimVie Financial information for ZimVie ...

Third Party Net Sales from Continuing Operations of $118.2 million Net Loss from Continuing Operations of ($11.5) million; Net Loss margin of (9.7%) Adjusted EBITDA [ 1] from Continuing Operations of $12.5 million; Adjusted EBITDA [ 1] margin of 10.5% ...

PALM BEACH GARDENS, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the first quarter 2024 after market close on Wednesday, May 8, 2024. Company management will host a cor...

2024-04-01 08:07:31 ET More on ZimVie ZimVie: Shrinking Its Way To Profitability ZimVie launches TSX dental implant product in Japan Read the full article on Seeking Alpha For further details see: H.I.G. Capital completes acquisition of the spine unit of ...